Isoquinolines and derivatives
Sigma Aldrich Fine Chemicals Biosciences Atracurium besylate United States Pharmacopeia (USP) Reference Standard | 64228-81-5 | MFCD00797403 | 100MG
Atracurium besylate United States Pharmacopeia (USP) Reference Standard | Mol Wt: 1243.48 | 64228-81-5 | MFCD00797403 | 100MG
Medchemexpress LLC Atracurium (besylate) | 64228-81-5 | 98.6% | 500 MG
Atracurium besylate is a potent, competitive, and non-depolarizing neuromuscular blocking agent. It also acts as an AChR receptor antagonist, inducing bronchoconstriction and neuromuscular blockade, and promoting astroglial differentiation.
- Potent, competitive, and non-depolarizing neuromuscular blocking agent
- AChR receptor antagonist
- Induces bronchoconstriction and neuromuscular blockade
- Promotes astroglial differentiation
- Reduces tumor engraftment in xenotransplanted GSCs
- Induces a complete fade of tetanic contraction in rat muscle cells
Apexbio Technology LLC Atracurium Besylate 64228-81-5 500mg
Atracurium Besylate (CAS 64228-81-5) is a non-depolarizing neuromuscular blocking agent that exerts its effects by competitively inhibiting acetylcholine receptors at the neuromuscular junction thereby interrupting neurotransmission between motor nerves and skeletal muscle In biomedical research it is utilized to induce neuromuscular blockade enabling studies of neurotransmitter release synaptic transmission mechanisms and regulation of muscle contraction Additionally Atracurium Besylate has been reported to elicit bronchoconstriction and promote differentiation of glial cells such as astrocytes supporting investigations into cellular differentiation and airway responsiveness
![eMolecules 159303-54-5 | (3S,6S,8AS)-METHYL 6-((TERT-BUTOXYCARBONYL)AMINO)-5-OXOOCTAHYDROINDOLIZINE-3-CARBOXYLATE | AstaTech | MFCD09038149 | 312.366 | C15H24N2O5 | 95.000 | COC(=O)[C@@H]1CC[C@@H]2CC[C@H](NC(=O)OC(C)(C)C)C(=O)N12 | 0.25g | 601098523](https://assets.fishersci.com/TFS-Assets/CCG/product-images/502180279.JPG-250.jpg)
eMolecules 159303-54-5 | (3S,6S,8AS)-METHYL 6-((TERT-BUTOXYCARBONYL)AMINO)-5-OXOOCTAHYDROINDOLIZINE-3-CARBOXYLATE | AstaTech | MFCD09038149 | 312.366 | C15H24N2O5 | 95.000 | COC(=O)[C@@H]1CC[C@@H]2CC[C@H](NC(=O)OC(C)(C)C)C(=O)N12 | 0.25g | 601098523
(3S,6S,8AS)-METHYL 6-((TERT-BUTOXYCARBONYL)AMINO)-5-OXOOCTAHYDROINDOLIZINE-3-CARBOXYLATE | AstaTech | 159303-54-5 | MFCD09038149 | 312.366 | C15H24N2O5 | 95.000 | COC(=O)[C@@H]1CC[C@@H]2CC[C@H](NC(=O)OC(C)(C)C)C(=O)N12 | 0.25g | 601098523
Medchemexpress LLC Atracurium (besylate) | 64228-81-5 | 98.6% | 50 MG
Atracurium besylate is a potent, competitive, and non-depolarizing neuromuscular blocking agent. It acts as an AChR receptor antagonist, inducing bronchoconstriction and neuromuscular blockade. This product promotes astroglial differentiation and is intended for research use only.
- Potent, competitive, and non-depolarizing neuromuscular blocking agent
- AChR receptor antagonist
- Induces bronchoconstriction and neuromuscular blockade
- Promotes astroglial differentiation
- Appearance: solid, white to off-white
![eMolecules 2664977-34-6 | (7S,8aS)-1,2,3,4,6,7,8,8a-octahydropyrrolo[1,2-a]pyrazin-7-ol oxalic acid | Pharmablock - Stock232.236 | C9H16N2O5 | 97.000 | OC(=O)C(O)=O.O[C@H]1C[C@H]2CNCCN2C1 | 1g | 534610478](https://assets.fishersci.com/TFS-Assets/CCG/product-images/502160078.JPG-250.jpg)
eMolecules 2664977-34-6 | (7S,8aS)-1,2,3,4,6,7,8,8a-octahydropyrrolo[1,2-a]pyrazin-7-ol oxalic acid | Pharmablock - Stock232.236 | C9H16N2O5 | 97.000 | OC(=O)C(O)=O.O[C@H]1C[C@H]2CNCCN2C1 | 1g | 534610478
(7S,8aS)-1,2,3,4,6,7,8,8a-octahydropyrrolo[1,2-a]pyrazin-7-ol oxalic acid | Pharmablock - Stock | 2664977-34-6232.236 | C9H16N2O5 | 97.000 | OC(=O)C(O)=O.O[C@H]1C[C@H]2CNCCN2C1 | 1g | 534610478
Sigma Aldrich Fine Chemicals Biosciences Papaverine hydrochloride powder | 61-25-6 | MFCD00012745 | 5G
Papaverine hydrochloride powder | Purity: >=98% | Mol Wt: 375.85 | 61-25-6 | MFCD00012745 | 5G
eMolecules 92932-74-6 | 1,2,3,4-Tetrahydro-isoquinoline-1-carboxylic acid hydrochloride | J & W PharmLab LLC | MFCD01829838 | 213.660 | C10H12ClNO2 | 96.000 | Cl.OC(=O)C1NCCc2ccccc12 | 250mg | 553408535
1,2,3,4-Tetrahydro-isoquinoline-1-carboxylic acid hydrochloride | J & W PharmLab LLC | 92932-74-6 | MFCD01829838 | 213.660 | C10H12ClNO2 | 96.000 | Cl.OC(=O)C1NCCc2ccccc12 | 250mg | 553408535
eMolecules 1203579-50-3 | 1,2,3,4-Tetrahydro-isoquinoline-5-carboxylic acid hydrochloride | J & W PharmLab LLC | MFCD14702500 | 213.660 | C10H12ClNO2 | 96.000 | Cl.OC(=O)c1cccc2CNCCc12 | 100mg | 495794117
1,2,3,4-Tetrahydro-isoquinoline-5-carboxylic acid hydrochloride | J & W PharmLab LLC | 1203579-50-3 | MFCD14702500 | 213.660 | C10H12ClNO2 | 96.000 | Cl.OC(=O)c1cccc2CNCCc12 | 100mg | 495794117
Chem-Impex International, Inc. 6-Hydroxyisoquinoline | 7651-82-3 | MFCD04114860 | 5G
6-Hydroxyisoquinoline, 7651-82-3, MFCD04114860, 5G
HELLO BIO INC Naloxone hydrochloride | 357-08-4 | MFCD00150901 | 100mg
Naloxone hydrochloride | Putity: >99% | MW: 363.84 | 357-08-4 | MFCD00150901 | 100mg
Chemscene ChemScene | 3,4-Dihydroisoquinolin-1(2H)-one | 10G | CS-W008863 | 0.97 | 1196-38-9| MFCD00853963 | 147.18
ChemScene | 3,4-Dihydroisoquinolin-1(2H)-one | 10G | CS-W008863 | 0.97 | 1196-38-9| MFCD00853963 | 147.18
Chem-Impex International, Inc. 3,4-Dihydro-2H-isoquinolin-1-one | 1196-38-9 | MFCD00853963 | 5G
3,4-Dihydro-2H-isoquinolin-1-one, 1196-38-9, MFCD00853963, 5G